Compliance to iron supplementation during pregnancy
Authors:
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 29 (6) , 487-492
Abstract
Iron deficiency anaemia is the most common nutritional disorder in the world. Pregnant women are at especially high risk of iron deficiency and anaemia because of significantly increased iron requirements during pregnancy. Iron supplementation during pregnancy has been recommended for women in the developing world, since usually no basic changes occur in the composition of the diet. This is a retrospective cohort study carried out in Al-Yamamah Hospital, Riyadh, Saudi Arabia, comparing the outcome of haemoglobin levels in 308 pregnant women near term with compliance to iron supplementation during the preceding pregnancy stages. Data were collected using an interview-based questionnaire for assessment of supplementation compliance and the women were divided into three categories: strictly compliant; partially compliant; and non-compliant. Haemoglobin levels were extracted from the medical records for the first antenatal visit (before 13 weeks' gestation) and compared with the level at entrance to the study at 36 weeks' gestation. Both Epi-info 2002 version 3.2 and SPSS version 10 were used for data analysis. Our results show that 49.7% used iron supplements continuously during the second and third trimesters of pregnancy; 38.3% reported partial use and 12.0% used no iron supplements. Haemoglobin levels improved significantly only among strictly compliant pregnant women, by 0.3 g/dl; decreased among partially compliant women by, 0.36 g/dl and significantly decreased among non-compliant, by –1.4 g/dl. Factors associated with non-compliance were education with a simple linear protective effect from being non-compliant. The percentage of anaemic women increased from 29.6% in the first trimester to 34% in the third trimester. Anaemia was significantly associated with non-compliance with iron supplementation, the adjusted OR was 6.19 95% CI 2.55–15.02, p < 0.0001. Strategies to improve compliance and effective iron supplementation among pregnant women should be implemented.Keywords
This publication has 11 references indexed in Scilit:
- Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case–control studyJournal of Epidemiology and Community Health, 2008
- Guidelines on anaemia: effect on primary-care midwives in The NetherlandsMidwifery, 2005
- Guidelines for iron supplementation in pregnancy: compliance among 431 parous Scandinavian womenEuropean Journal of Clinical Pharmacology, 2003
- Micronutrient Status during Pregnancy and Outcomes for Newborn Infants in Developing CountriesThe Journal of Nutrition, 2003
- Iron supplementation in pregnancyJournal of Perinatal Medicine, 2003
- Iron Deficiency and Anaemia in Pregnancy: Modern Aspects of Diagnosis and TherapyBlood Cells, Molecules, and Diseases, 2002
- Effects of Iron Supplementation on Maternal Hematologic Status in PregnancyAmerican Journal of Public Health, 2002
- WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal careThe Lancet, 2001
- Effectiveness and strategies of iron supplementation during pregnancyThe American Journal of Clinical Nutrition, 2000
- Folate, vitamin D, and iron intakes are low among pregnant Finnish womenEuropean Journal of Clinical Nutrition, 1998